Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment Study completion moved earlier from May 1, 2027 to Dec 31, 2026
- Minor: IParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients Study completion pushed from Jun 26, 2026 to Mar 31, 2027
- Minor: Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion Interventions modified
- Minor: COINCIDE · Cardineurovascular dIsease and Obstructive Airway Disease Start date pushed from Oct 15, 2026 to Nov 2026
- Minor: Using Facebook to Support Opioid Recovery Among American Indian Women Study completion pushed from Oct 31, 2026 to Oct 15, 2027
- Minor: Music Improvisation Training on Cognitive Function in Older Adults Study completion pushed from Jun 12, 2026 to Jun 12, 2027
- Minor: CHIP in Health and Disease Start date pushed from Oct 2026 to Nov 2026
- Minor: Maastro Applicator in Rectal Cancer Study completion moved earlier from Apr 2031 to Oct 6, 2030
- Minor: MDMA-assisted Therapy for Fibromyalgia Trial arms changed: 0 → 1
- Minor: COVID-19 Vaccine(s) in Children and Adults Enrollment closed, study ongoing
- Minor: Depemokimab Compared With Mepolizumab · Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) Trial completed
- Minor: AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) · Anemia Enrollment closed, study ongoing
- Minor: PF-06821497 (Mevrometostat) Works · Metastatic Castration-resistant Prostate Cancer Enrollment closed, study ongoing
- Minor: Balcinrenone/Dapagliflozin · Heart Failure and Impaired Kidney Function Enrollment closed, study ongoing
- Minor: Linerixibat Long-term Safety, and Tolerability Study Trial completed
- Minor: HRS-5965 Capsule in Primary IgA Nephropathy Enrollment closed, study ongoing
- Minor: CATALINA-2 · TORL-1-23 in Platinum-resistant Ovarian Cancer Enrollment closed, study ongoing
- Minor: A2B395, an Allogeneic Logic-gated CAR T, · Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Enrollment closed, study ongoing
- Minor: Microdystrophin Gene Transfer Study in Adolescents and · DMD Trial completed
- Minor: Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age Enrollment closed, study ongoing
- Minor: SB17170 Phase 2 Trial in IPF Patients Trial completed
- Minor: CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL) Trial completed
- Minor: CDR404 in HLA-A*02:01 · MAGE-A4 Expressing Solid Tumors Enrollment closed, study ongoing
- Minor: CX-5461 · Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation Enrollment closed, study ongoing
- Minor: Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates